Enabling high giant magnetoresistance in simple spin valves with ultrathin seed and free layers
Applied Physics Letters · 30.03.2026 · 128 (13)
DOI: 10.1063/5.0319854 ↗Kurz gefasst
Fachartikel in der Zeitschrift Applied Physics Letters, online erschienen am 30.03.2026. Verfasst von Sachli Abdizadeh und 5 weiteren Autor:innen. Die Arbeit nennt 51 Literaturangaben. Gefördert von: National Science Foundation, Luther and Alice Hamlett Undergraduate Research Support.
Abstract (Originalsprache)
Emerging spin–orbit torque devices based on spin valves require a thin magnetic free layer to maximize the torque per moment. However, reducing the free-layer thickness to ≲2 nm deteriorates the giant magnetoresistance (GMR) signal for electrical readout. Here, we demonstrate that the addition of a 1 nm Cu seed layer promotes sharp interfaces in simple polycrystalline Co-based spin valves, enabling high GMR ratios of 5%–7% at sub-2 nm free-layer thicknesses. Our work offers a pathway for engineering high-signal GMR readout in spin–orbit torque digital memories and neuromorphic computers.
Förderung
- National Science Foundation
- Luther and Alice Hamlett Undergraduate Research Support
Zitieren
APA
Abdizadeh, S., Maizel, R. E., Haymore, D. L., Zhao, J., Michel, F. M., & Emori, S. (2026). Enabling high giant magnetoresistance in simple spin valves with ultrathin seed and free layers. Applied Physics Letters, 128(13). https://doi.org/10.1063/5.0319854
Vancouver
Abdizadeh S, Maizel RE, Haymore DL, Zhao J, Michel FM, Emori S. Enabling high giant magnetoresistance in simple spin valves with ultrathin seed and free layers. Applied Physics Letters. 2026;128(13). doi:10.1063/5.0319854
BibTeX
@article{Abdizadeh2026,
author = {Abdizadeh, Sachli and Maizel, Rachel E. and Haymore, Dylan L. and Zhao, Jing and Michel, F. Marc and Emori, Satoru},
title = {Enabling high giant magnetoresistance in simple spin valves with ultrathin seed and free layers},
journal = {Applied Physics Letters},
year = {2026},
volume = {128},
number = {13},
doi = {10.1063/5.0319854}
}
EUVIMED